A Phase-2 Study On The Efficacy Of Low-Dose Anandamide Plus A Neuroendocrine Regimen With High-Dose Melatonin And Low-Dose Angiotensin 1-7 In Patients Affected By Untreatable Glioblastoma
Paolo Lissoni, Franco Rovelli, Giusy Messina, Alejandra Monzon, Andrea Sassola, Pasquale Palazzo, Tommaso Pellegatti, Giuseppe Di Fede, Daniel Pedro Cardinali*